According to DexCom's latest financial reports the company's current earnings (TTM) are $0.73 B. an increase over its 2022 earnings that were of $0.41 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $0.73 B | 78.13% |
2022 | $0.41 B | 47.34% |
2021 | $0.27 B | -10.11% |
2020 | $0.30 B | 88.27% |
2019 | $0.16 B | -258.48% |
2018 | -$0.11 B | 189.94% |
2017 | -$35.8 M | -44.24% |
2016 | -$64.2 M | 12.43% |
2015 | -$57.1 M | 165.58% |
2014 | -$21.5 M | -25.61% |
2013 | -$28.9 M | -48.11% |
2012 | -$55.7 M | 24.5% |
2011 | -$44.74 M | |
2008 | -$52.83 M | 13.18% |
2007 | -$46.68 M | -5.36% |
2006 | -$49.33 M | 52.08% |
2005 | -$32.43 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | 2,222.70% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $6.66 B | 812.00% | ๐บ๐ธ USA |
Medtronic MDT | $6.23 B | 753.29% | ๐ฎ๐ช Ireland |
Becton Dickinson BDX | $1.54 B | 110.76% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $1.61 B | 121.12% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | -$0.23 B | -130.14% | ๐บ๐ธ USA |
QuidelOrtho QDEL | -$29.1 M | -103.98% | ๐บ๐ธ USA |
West Pharmaceutical WST | $0.69 B | -4.48% | ๐บ๐ธ USA |